The pharmaceutical landscape is undergoing a structural realignment, anchored by the resurgence of oral solid dosage (OSD) platforms and the…
Read More
High-Dose Fish Oil Supplements Fail to Slow Cognitive Decline in Older Adults at Risk for Alzheimer’s Disease Despite Successful Brain Penetration
The multi-billion-dollar global industry built around omega-3 fatty acid supplements has faced a significant scientific setback following the release of…
Read More
Exercise and Low-Dose Ibuprofen Show Promise in Mitigating Chemotherapy-Induced Cognitive Impairment
For decades, cancer survivors have reported a cloud of mental fog following treatment, a phenomenon colloquially termed "chemo brain." This…
Read More
UK Approves Lower Dose of Needle-Free Adrenaline Nasal Spray for Young Children
The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for a new, lower dose of ALK-Abelló’s…
Read More
Novo Nordisk’s Wegovy Poised for Significant European Expansion Following Positive CHMP Opinions on Oral and High-Dose Injectable Formulations
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has delivered two pivotal positive opinions, paving…
Read More
